Centers for Disease Control and Prevention

Listen and learn from nationally recognized experts in these 15-minute podcasts about the importance and effectiveness of starting buprenorphine treatment for opioid use disorder (OUD) in emergency departments. Hospital leaders receive research-backed advice on the technology tools, clinical evidence, and referral networks that support this safe and effective first-line treatment in the ED – and how this research has been translated into action.

Summarizes how opioid use disorder is diagnosed using the DSM-5 assessment criteria, how to discuss this diagnosis with patients, and how to treat opioid use disorder. CE available.

Shares benefits of buprenorphine for treating opioid use disorder, including its versatility for initiation in multiple clinical settings and effectiveness in reducing illicit opioid use.

Information on naltrexone and methadone can be found in the Assessing and Addressing Opioid Use Disorder module, and additional trainings will be developed.

This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years.